We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$66.4B
AUM Growth
+$5.93B
(+9.8%)
Cap. Flow
-$619M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
13.02%
Holding
3,510
New
779
Increased
864
Reduced
1,015
Closed
774
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$500M |
| 2 |
Arista Networks
ANET
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$271M |
| 4 |
Eli Lilly
LLY
|
+$271M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$495M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$388M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$369M |
| 5 |
Mastercard
MA
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Consumer Discretionary | 9.99% |
| 3 | Financials | 9.73% |
| 4 | Industrials | 7.81% |
| 5 | Healthcare | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIGR
1626
UP Fintech Holding
TIGR
$833M
| $2.37M | ﹤0.01% |
+245,929
| New | +$2.06M |
|
1627
Solid Biosciences
SLDB
$974M
| $2.37M | ﹤0.01% |
487,123
-140,151
| -22% | -$495K |
|
1628
Simmons First National
SFNC
$3.46B
| $2.37M | ﹤0.01% |
125,076
+24,994
| +25% | +$471K |
|
1629
CNA Financial
CNA
$13.8B
| $2.36M | ﹤0.01% |
+50,807
| New | +$2.41M |
|
1630
PUT
Abercrombie & Fitch
ANF
$4.84B
| $2.36M | ﹤0.01% |
28,500
| – | – |
|
|
PDO
1631
PIMCO Dynamic Income Opportunities Fund
PDO
$1.84B
| $2.36M | ﹤0.01% |
+174,862
| New | +$2.33M |
|
1632
CALL
AbbVie
ABBV
$443B
| $2.34M | ﹤0.01% |
12,600
-77,300
| -86% | -$14.4M |
|
1633
Delta Air Lines
DAL
$60B
| $2.34M | ﹤0.01% |
47,534
-14,009
| -23% | -$643K |
|
1634
Dell
DELL
$320B
| $2.33M | ﹤0.01% |
18,975
-248,003
| -93% | -$25.3M |
|
1635
CALL
Vertex Pharmaceuticals
VRTX
$131B
| $2.32M | ﹤0.01% |
+5,200
| New | +$2.4M |
|
1636
3M
MMM
$94.2B
| $2.3M | ﹤0.01% |
15,136
+11,715
| +342% | +$1.67M |
|
1637
PUT
VanEck Oil Services ETF
OIH
$1.95B
| $2.3M | ﹤0.01% |
10,000
-300
| -3% | -$67.3K |
|
1638
CALL
Symbotic
SYM
$5.43B
| $2.3M | ﹤0.01% |
59,200
-13,100
| -18% | -$343K |
|
1639
Axos Financial
AX
$5.72B
| $2.3M | ﹤0.01% |
+30,228
| New | +$2.04M |
|
1640
LivaNova
LIVN
$4.53B
| $2.3M | ﹤0.01% |
51,006
-400,244
| -89% | -$16.5M |
|
1641
Star Holdings Shares of Beneficial Interest
STHO
$117M
| $2.3M | ﹤0.01% |
293,879
-21,401
| -7% | -$148K |
|
1642
Diamondback Energy
FANG
$55.9B
| $2.29M | ﹤0.01% |
16,681
-252,215
| -94% | -$34.9M |
|
1643
Sinclair Inc
SBGI
$1.03B
| $2.29M | ﹤0.01% |
+165,827
| New | +$2.36M |
|
|
PCAPU
1644
ProCap Acquisition Corp Unit
PCAPU
$213M
| $2.28M | ﹤0.01% |
+212,948
| New | +$2.36M |
|
1645
Quanta Services
PWR
$101B
| $2.28M | ﹤0.01% |
6,031
-8,505
| -59% | -$2.73M |
|
1646
CALL
Constellation Brands
STZ
$23.3B
| $2.28M | ﹤0.01% |
14,000
| – | – |
|
1647
Anavex Life Sciences
AVXL
$303M
| $2.26M | ﹤0.01% |
245,624
+74,241
| +43% | +$634K |
|
1648
PUT
Sysco
SYY
$40B
| $2.26M | ﹤0.01% |
29,900
-100,000
| -77% | -$7.26M |
|
1649
M&T Bank
MTB
$36.6B
| $2.26M | ﹤0.01% |
11,663
+7,563
| +184% | +$1.33M |
|
1650
BioCryst Pharmaceuticals
BCRX
$2.51B
| $2.26M | ﹤0.01% |
252,414
-333,792
| -57% | -$3.11M |
|
Similar funds
BC
Balyasny Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Balyasny Asset Management held 3,510 positions worth $66.4B, up 9.8% from $60.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Balyasny Asset Management's Q2 2025 filing shows 779 new, 864 increased, 1,015 reduced and 774 closed positions. Its largest new stake was Arista Networks: 3,646,977 shares worth $373M. The largest sale was iShares Core S&P 500 ETF, an estimated $495M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
- Balyasny Asset Management's largest Q2 2025 buy was Arista Networks: 3,646,977 shares worth $373M.
- Balyasny Asset Management added most to Brown & Brown in Q2 2025, an estimated $500M increase.
- Balyasny Asset Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $495M.
- Balyasny Asset Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2025, selling an estimated $369M.
- Balyasny Asset Management's ten largest holdings make up 13% of its $66.4B portfolio in Q2 2025.
- Balyasny Asset Management opened 779 new positions and closed 774 in Q2 2025.
- Balyasny Asset Management's portfolio value rose 9.8% quarter-over-quarter to $66.4B.
Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.